• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

VI Partners

edit

VI Partners is a Swiss venture capital firm that supports university spin-offs as well as other promising start-up companies with capital, coaching, consulting and networks. Via their current “Venture Incubator” fund VI Partners invests “Smart Money” to develop promising technology-based ideas for products and services into successful businesses. Venture Incubator was established by McKinsey & Company and the Swiss Federal Institute of Technology in Zürich (ETHZ), and started operations in 2001. It now manages an investment fund of CHF 101 million. Their investors represent 10 blue-chip enterprises from industry and finance.

Milestones

edit

• 
  VI Partners invested in Delenex Therapeutics. (5/3/11)
  Posted 5/3/11 at 6:04pm via finsmes.com
• 
  VI Partners invested in NovaShunt. (3/9/11)
  Posted 3/9/11 at 5:57am via prnewswire.com
• 
  VI Partners invested in Activaero. (2/16/11)
  Posted 2/16/11 at 6:15pm via cnbc.com
• 
  VI Partners invested in Delenex Therapeutics. (11/12/10)
  Posted 11/14/10 at 6:38pm via finsmes.com
• 
  VI Partners invested in NemeriX. (9/8/05)
  Posted 10/1/10 at 3:16am via eetimes.com
• 
  VI Partners invested in Covalys Biosciences. (2/1/05)
  Posted 8/31/10 at 11:32pm
• 
  VI Partners invested in Silentsoft. (2/1/10)
  Posted 7/22/10 at 2:37am
• 
  VI Partners invested in NEXThink. (6/1/10)
  Posted 7/11/10 at 11:35am
• 
  VI Partners invested in ESBATech. (8/2/06)
  Posted 4/19/10 at 7:51pm via esbatech.com
• 
  VI Partners invested in Visonys. (2/1/06)
  Posted 4/12/10 at 9:15pm
• 
  VI Partners invested in NEXThink. (3/7/07)
  Posted 3/25/10 at 7:39am via nexthink.com
• 
  VI Partners invested in NemeriX. (9/17/07)
  Posted 2/15/10 at 1:36am via design-reuse.com
• 
  VI Partners invested in Activaero. (11/20/09)
  Posted 11/20/09 at 8:24pm via businesswire.com
• 
  VI Partners invested in Endosense. (10/27/09)
  Posted 10/28/09 at 3:18am via onbiovc.com
• 
  VI Partners invested in ESBATech. (8/7/08)
  Posted 6/24/09 at 12:46am via fiercebiotech.com

Investments

Videos

Sources

1. Delenex Therapeutics Raises $19.3M (finsmes.com) [edit]
2. NovaShunt AG Raises $25 Million in a Series B Financing Co-Led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund (prnewswire.com) [edit]
3. Activaero Raises EUR 5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP (cnbc.com) [edit]
4. Delenex Therapeutics Closes CHF13.5M Series A Venture Capital Financing Round (finsmes.com) [edit]
5. Cap Funding Report [edit]
6. Cap Funding Report [edit]
7. Activaero, GmbH: Series A $15.9M (businesswire.com) [edit]
8. Endosense, SA: Series B $36M (onbiovc.com) [edit]
9. ESBATech rounds up $22M in second round (fiercebiotech.com) [edit]
10. NemeriX Receives $22M in Series-C Funding (design-reuse.com) [edit]
11. NEXThink secures CHF 6 Million in Second Round of Funding (nexthink.com) [edit]
12. ESBATech Closes USD 41M Series B Venture Financing (esbatech.com) [edit]
13. Cap Funding Report [edit]
14. Cadence backs startup in $31 million VC round (eetimes.com) [edit]
15. Cap Funding Report [edit]